Results 171 to 180 of about 112,758 (355)
Genome Diversity of Epstein-Barr Virus from Multiple Tumor Types and Normal Infection [PDF]
Anne Palser +14 more
openalex +1 more source
Epidemiology and clinical characteristics of Epstein-Barr virus infection among children in Shanghai, China, 2017-2022 [PDF]
Zhicheng Ye +5 more
openalex +1 more source
Human Spinal Cord GABAergic Neural Progenitor Cell
Cell Proliferation, EarlyView.
Jia Xu +23 more
wiley +1 more source
Successful Treatment of Severe Purpura Fulminans With Anakinra
ABSTRACT Purpura fulminans (PF) is a rare, often fatal pediatric condition characterized by intravascular thrombosis and hemorrhagic infarction of the skin. A timely diagnosis and treatment are paramount to prevent the involvement of internal organs, causing disseminated intravascular coagulation and gangrene of the extremities.
Francesco Zulian +4 more
wiley +1 more source
The Role of Pre-therapeutic 18F-FDG PET/CT in Pediatric Hemophagocytic Lymphohistiocytosis With Epstein-Barr Virus Infection [PDF]
Xia Lu +9 more
openalex +1 more source
Abstract Hundreds of millions of people have one or more missing teeth. Consequently, a substantial number of patients undergo implant therapy each year. However, technical complications and soft tissue inflammation associated with the implant abutment or the type of restoration can lead to bone loss and, ultimately, implant failure.
Yasir Nabeel Al‐Mohammad +13 more
wiley +1 more source
EPSTEIN-BARR VIRUS INFECTIONS – AVIDITY TEST FOR IgG ANTIBODIES
Background. We wish to introduce specific IgG avidity test as a supplementary assay in serological screening for Epstein-Barr virus infection if the status of patient cannot be resolved from a single serum sample with routine testing.Methods.
Katja Strašek, Jožica Marin
doaj
Efficiency of Different Serological Methods for Diagnosing Epstein−Barr Virus Infection and Atypical Serological Profiles [PDF]
Firdevs Güvenç +6 more
openalex +1 more source
A sudden increase in EBV DNAemia appears to be a better predictor of PTLD and EBV end‐organ disease than persistent and stable levels of EBV DNAemia. Most HCT recipients with EBV DNAemia did not require rituximab, and immunosuppression reduction was sufficient to control most episodes of EBV reactivation.
Anna Beatriz Coelho de Souza +12 more
wiley +1 more source
Chronic Epstein-Barr virus infection.
no
Pallavicini, E B +5 more
openaire +1 more source

